Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.54 |
| ▸ | MAOB | P27338 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | NOS1 | P29475 | 1/20 | 0.52 |
| ▸ | HMOX2 | P30519 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28686953 | 0.89 | RAB9A (0.59) | ALDH1A1KMT2AMAPTKDM4EMAOB | |
| SCHEMBL2801030 | 0.88 | MAOB (0.60) | ALDH1A1KMT2AMAPTKDM4EMAOB | |
| SCHEMBL7162438 | 0.86 | MAOB (0.62) | ALDH1A1KMT2AMAPTKDM4EMAOB | |
| SCHEMBL13883739 | 0.84 | MAOB (0.64) | ALDH1A1KMT2AMAPTKDM4EMAOB | |
| SCHEMBL23071123 | 0.83 | ALDH1A1 (0.55) | ALDH1A1KMT2AMAPTKDM4EMAOB | |
| SCHEMBL30379123 | 0.83 | ALDH1A1 (0.55) | ALDH1A1KMT2AMAPTKDM4EMAOB | |
| SCHEMBL5922423 | 0.81 | ALDH1A1 (0.57) | ALDH1A1KMT2AMAPTKDM4EMAOB | |
| SCHEMBL2570157 | 0.81 | TSHR (0.62) | ALDH1A1KMT2AMAPTKDM4EMAOB | |
| SCHEMBL12370654 | 0.81 | ALDH1A1 (0.54) | ALDH1A1KMT2AMAPTKDM4EMAOB | |
| SCHEMBL6772688 | 0.81 | ALDH1A1 (0.54) | ALDH1A1KMT2AMAPTKDM4EMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3480224-B1 | ELECTRO-OPTIC POLYMER | NAT INST INF & COMM TECH (JP) | 2024-06-12 | — | — | EP | disclosed |
| US-11236188-B2 | Electro-optic polymer | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY (JP) | 2022-02-01 | — | — | US | disclosed |
| US-20190225728-A1 | ELECTRO-OPTIC POLYMER | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY (JP) | 2019-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190225728-A1 | ELECTRO-OPTIC POLYMER | UACA, ELAVL1, EYA3 | ALDH1A1 216/4885KMT2A 1928/4885MAPT 672/4885 |
| US-11236188-B2 | Electro-optic polymer | UACA, ELAVL1, EYA3 | ALDH1A1 216/4885KMT2A 1928/4885MAPT 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.